Exhibition information:

meeting time：

From October 31st to November 2nd, 2025

Meeting location:

Grand Metropark Hotel Nanjing

No. 319 Zhongshan East Road, Xuanwu District, Nanjing

Organizer

Chinese Particle Society Inhalation Particle Professional Committee

Nanjing Normal University

Nuoze has been engaged in the field of inhalation preparation equipment for many years, with a good reputation and a large customer base. We strive to provide suitable solutions for every customer.

Our company has a GMP compliant purification workshop and a micro nano technology experimental center, providing equipment and technical solutions for different stages of production from experimental to large-scale production needs.

Regarding the application of ultrafine powder airflow pulverizers and micro jet homogenizers in inhalation formulations, Nuoze has conducted numerous studies and written technical articles for reference. You can click on the account homepage to view them.

Welcome to call or leave a message for consultation!

·Exhibition Introduction

The Inhalation Particle Special Committee of the Chinese Particle Society was established in 2018 and is a subsidiary branch of the Chinese Particle Society. Its predecessor was the "Inhalation Drug Administration Alliance". The members of the Inhalation Particle Expert Committee mainly include a group of professionals in the field with a high foundation in inhalation drug development, such as drug research and production enterprises, experts and scholars from universities and institutions. The Inhalation Particle Expert Committee is guided by relevant drug laws, regulations, and policies formulated by national government agencies, with the aim of promoting the development of China's inhalation drug delivery industry, improving domestic research and development, product technical standards, and clinical applications of inhalation drugs, and accelerating integration with international peers. The alliance actively promotes the overall development of the inhalation drug delivery industry in China by mobilizing domestic resources in drug research, drug production, quality monitoring, and clinical applications.